Register entry

Lianyungang Runzhong Pharmaceutical Co., Ltd.,

Registered sites
1
Drug products
11
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Active ingredient (API) manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
Lianyungang Runzhong Pharmaceutical Co., Ltd.LianyungangChinaActive ingredient (API) manufacture3003015655
Catalogue

Marketed products

11

Showing 11 of 11.

BrandGeneric nameFormCategory
-AmifostinePOWDERBULK INGREDIENT
-CarfilzomibPOWDERBULK INGREDIENT
-Catequentinib HydrochloridePOWDERBULK INGREDIENT
-Degarelix AcetatePOWDERBULK INGREDIENT
-Eribulin MesylatePOWDERBULK INGREDIENT
-Fosaprepitant DimegluminePOWDERBULK INGREDIENT
-Foscarnet SodiumPOWDERBULK INGREDIENT
-FulvestrantPOWDERBULK INGREDIENT
-Gadoxetate DisodiumPOWDERBULK INGREDIENT
-PalbociclibPOWDERBULK INGREDIENT
-Tiotropium Bromide MonohydratePOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.